This Article Reprint (PDF) Submit a response to this article Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to Citation Manager Reprints & Permissions Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (5) Citing Articles via Google Scholar Google Scholar Articles by Mitchell, J. M. Articles by Anderson, K. H. Search for Related Content PubMed PubMed Citation Articles by Mitchell, J. M. Articles by Anderson, K. H. Related Collections Access To Care Medicaid Pharmaceuticals Health Spending

Health Affairs, Vol 19, Issue 4, 233-243
Copyright © 2000 by Project HOPE

DataWatch

Effects of case management and new drugs on Medicaid AIDS spending

This study evaluates the effects of Florida's participation in the Medicaid acquired immunodeficiency syndrome (AIDS) home and community-based waiver and the use of recently developed AIDS drugs on spending per Medicaid beneficiary. We find that monthly Medicaid spending for waiver non-participants was significantly higher than was spending for waiver nonparticipants. The major reason for the cost difference is that nonwaiver enrollees incurred significantly higher inpatient costs than did those enrolled in the waiver. Although waiver enrollees had higher drug spending, these represent only a fraction of the higher inpatient costs incurred by nonwaiver enrollees. Thus, it appears that adherence to appropriate medications reduces the need for inpatient care. The case management approach of the AIDS waiver may have similar effects for persons with other chronic diseases.

                      What's this?

This article has been cited by other articles:

				R. Steinbrook Providing Antiretroviral Therapy for HIV Infection N. Engl. J. Med., March 15, 2001; 344(11): 844 - 846. [Full Text] [PDF]

				K. H. Anderson and J. M. Mitchell Differential Access in the Receipt of Antiretroviral Drugs for the Treatment of AIDS and Its Implications for Survival Arch Intern Med, November 13, 2000; 160(20): 3114 - 3120. [Abstract] [Full Text] [PDF]